Transgene Appoints Two Seasoned Leaders in Oncology to Drive its Next Phase of Innovation
Newly appointed CMO, Dr. Emmanuelle Dochy, and newly appointed CSO, Dr. Maurizio Ceppi, bring a strong track record of advancing cancer immunotherapies and precision medicine through clinical development as Transgene progresses its innovative preclinical and clinical pipeline including ...
| Ticker |
Sentiment |
Impact |
|
ITOS
|
Neutral
|
3 %
|
|
SNY
|
Neutral
|
6 %
|
|
TRGNF
|
Somewhat Bullish
|
42 %
|
